Weight-loss drugs sell in Europe for a fraction of what they cost in the United States, a pattern that is typical for ...

Novo Nordisk CEO Lars Fruergaard Jorgensen will testify Tuesday before a Senate panel looking into the drug maker's pricing ...

Is Ozempic and Wegovy maker Novo Nordisk helping Americans save taxpayer money or ripping them off? The company's CEO is ...

The CEO of Novo Nordisk is set to face pointed questions on Capitol Hill Tuesday about the prices of the Danish ...

Novo Nordisk chief executive Lars Fruergaard Jørgensen faced questioning on Capitol Hill over the health care costs of the ...

For the millions of people living with diabetes or obesity, drugs like Ozempic and Wegovy can significantly improve their ...

Ozempic and Wegovy are some of the most popular drugs in the country, driven by their remarkable success in treating diabetes ...

智通财经注意到，Ozempic 和 Wegovy 为诺和诺德（NVO.US）公司赚取了巨额利润，它们的累计销售额很快就会超过这家制药商过去 30 ...

智通财经APP注意到，Ozempic 和 Wegovy 为 诺和诺德 (NVO.US)公司赚取了巨额利润，它们的累计销售额很快就会超过这家制药商过去 30 年的全部研发预算。而 ...

The CEO of Novo Nordisk wouldn’t commit to lowering the prices of Ozempic and Wegovy during a Senate hearing Tuesday, despite ...

The high price of some popular weight loss drugs is at the center of a congressional committee on Tuesday with a ...

今天，在美国参议院卫生、教育、劳工和养老金委员会的听证会上，诺和诺德公司CEO Lars Jorgensen将面对参议员Bernie Sanders关于公司减肥和糖尿病药物定价的质询。这些药物Wegovy和Ozempic在美国的定价显著高于一些欧洲国家，美国的挂牌价分别为每月供应量1,349.02美元和935.77美元。 作为委员会主席的Sanders预计将就向美国付款方收取比其他任何国家更高的药 ...